Low thyroid levels may signal heightened risk of death in hospitalized patients

October 30, 2013

Chevy Chase, MD--Older individuals hospitalized with a serious condition may face a slimmer risk of surviving if their thyroid hormone levels are low, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

The thyroid gland, located in the neck, produces hormones that regulate the body's temperature, consumption of oxygen and metabolism. The gland produces two hormones, triiodothyronine (T3) and thyroxine (T4), which travel through the blood to spur activity in various tissues.

"When older individuals have low levels of thyroid hormones, particularly T3, it reflects that the body is weak and more susceptible to the harmful effects of disease," said the study's first author Pedro Iglesias, MD, of Hospital Ramón y Cajal in Madrid, Spain. "As a result, older individuals who have a reduced ability to synthesize T3 hormones have a higher rate of mortality, both in the short- and long-term."

As part of the prospective observational study, researchers measured thyroid hormone levels in all patients who were 65 years of age or older when they were admitted to the Hospital General in Segovia, Spain in 2005. For 404 patients, researchers tracked the length of hospital stay and the survival rate among the group as of Jan. 1, 2012.

During the seven-year study, 323 patients died. The study found an association between low levels of thyroid hormones and mortality. The analysis found low levels of thyroid hormone, in particular T3, tended to be a predictor for all-cause mortality. The patients in the group with the lowest levels of T3 hormones and thyroid-stimulating hormone, which the body uses to activate the thyroid gland, also had higher rates of death from cardiovascular disease.

"T3 could be a useful measure for gauging an older individual's chances of surviving an acute illness requiring hospitalization," Iglesias said. "The reduced ability to synthesize the hormone observed in this group of patients could be related to the severity of the disease and its prognosis."
-end-
Other researchers working on the study include: E. Ridruejo, A. Muñoz, F. Prado, M. Macías, M. Guerrero, P. Tajada and C. García-Arévalo of Hospital General in Segovia, Spain, and J.J. Díez of Hospital Ramón y Cajal in Madrid, Spain.

The article, "Thyroid Function Tests and Mortality in Aged Hospitalized Patients: a 7-year Prospective Observational Study," is scheduled to appear in the December 2013 issue of JCEM.

Founded in 1916, The Endocrine Society is the world's oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 16,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.

The Endocrine Society

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.